Synthesis of 4-substituted pyrano[4,3-b]pyran-2,5-diones in an ionic liquid

[1]  J. Khurana,et al.  Nickel nanoparticles catalyzed chemoselective Knoevenagel condensation of Meldrum’s acid and tandem enol lactonizations via cascade cyclization sequence , 2011 .

[2]  K. Rad‐Moghadam,et al.  Synthesis of symmetrical and unsymmetrical 3,3-di(indolyl)indolin-2-ones under controlled catalysis of ionic liquids , 2010, Tetrahedron.

[3]  K. Rad‐Moghadam,et al.  Indole 3-alkylation/vinylation under catalysis of the guanidinium ionic liquids , 2009 .

[4]  N. Zanatta,et al.  Ionic liquids in heterocyclic synthesis. , 2008, Chemical reviews.

[5]  J. Y. Kim,et al.  Src kinase‐targeted anti‐inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide‐activated RAW264.7 cells , 2008, British journal of pharmacology.

[6]  Xiu-Sheng Miao,et al.  Synthetic methods for the preparation of ARQ 501 (beta-Lapachone) human blood metabolites. , 2008, Bioorganic & medicinal chemistry.

[7]  I. Yavari,et al.  Proline-Promoted Efficient Synthesis of 4-Aryl-3,4-dihydro-2H,5H-pyrano[3,2-c]chromene-2,5-diones in Aqueous Media , 2008 .

[8]  Chi P. Ndi,et al.  Antimicrobial compounds from Eremophila serrulata. , 2007, Phytochemistry.

[9]  U. Beifuss,et al.  Efficient synthesis of substituted 7-methyl-2H,5H-pyrano[4,3-b]pyran-5-ones and evaluation of their in vitro antiproliferative/cytotoxic activities. , 2007, Bioorganic & medicinal chemistry letters.

[10]  L. Pardo,et al.  Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line. , 2007, Journal of medicinal chemistry.

[11]  L. Paquette,et al.  A modular approach to marine macrolide construction. 4. Assembly of C36-C51 and C29-C44 building blocks and evaluation of key coupling reactions targeting spongistatin 1 (altohyrtin A). , 2007, Organic letters.

[12]  J. Deschamps,et al.  Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and nor , 2006, Journal of medicinal chemistry.

[13]  K. Pupek,et al.  Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis. , 2006, Bioorganic & medicinal chemistry.

[14]  J. Tanaka,et al.  Enantioselective enol lactone synthesis under double catalytic conditions. , 2005, Organic letters.

[15]  J. Yadav,et al.  Montmorillonite KSF clay-promoted synthesis of enantiomerically pure 5-substituted pyrazoles from 2,3-dihydro-4H-pyran-4-ones , 2004 .

[16]  A. F. Dos Santos,et al.  Synthesis and evaluation of the molluscicidal activity of the 5,6-dimethyl-dihydro-pyran-2,4-dione and 6-substituted analogous. , 2004, Bioorganic & medicinal chemistry.

[17]  K. Rad‐Moghadam,et al.  A Route to the Synthesis of Novel Coumarins , 2004 .

[18]  A. Goel,et al.  Synthesis of bridgedhead azolo[3,2-a]pyrimidines and imidazo[2,1-b]thiazines through ring transformation of 2H-pyran-2-ones , 2003 .

[19]  A. Goel,et al.  A diversity oriented synthesis of highly functionalized unsymmetrical biaryls through carbanion induced ring transformation of 2H-pyran-2-ones , 2002 .

[20]  R. Hsung,et al.  The total synthesis of (±)-arisugacin A☆ , 2002 .

[21]  S. Ōmura,et al.  The first total synthesis of (+/-)-arisugacin A, a potent, orally bioavailable inhibitor of acetylcholinesterase. , 2002, Organic letters.

[22]  S. Ōmura,et al.  Convergent synthesis of arisugacin skeletons and their acetylcholinesterase inhibitory activity. , 2001, The Journal of antibiotics.

[23]  C. Lanzi,et al.  Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases. , 2000, Phytochemistry.

[24]  S. Ōmura,et al.  Structure-activity relationships of pyripyropenes fungal acyl-CoA: cholesterol acyltransferase inhibitors. , 1995, The Journal of antibiotics.

[25]  S. Ōmura,et al.  Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. I. Production, isolation, and biological properties. , 1994, The Journal of antibiotics.

[26]  L. Tietze.  Secologanin, a Biogenetic Key Compound—Synthesis and Biogenesis of the Iridoid and Secoiridoid Glycosides , 1983 .